Priyanka Dayal McCluskey
Massachusetts biotech incentives eclipsed by competitive states
Massachusetts has made its way over the past half-dozen years to being an undisputed leader in biotechnology and life sciences ...
Full genome sequencing is medically promising, but still expensive
Genome sequencing holds great potential for diagnosing diseases, finding treatments and ultimately cutting medical costs, experts say, but insurance companies ...
Precision medicine: reading genes and treating people before they get sick
Doctors and researchers around Boston are working to make drugs and health care delivery more individualized than ever. And patients ...